Vall d'Hebron Talks by VHIR 'CAAR-Tcell technology and nanomedicine as new alternatives for treatment of lupus nephritis'

 Vall d'Hebron Talks by VHIR
  Sala d’actes de la planta baixa de l'edifici Collserola del VHIR — See in map
28/09/2023
28/09/2023 -- From 14:00h to 15:00h
Organize :
Vall d'Hebron Institut de Recerca (VHIR)
Modality: Presencial
Share it:

Speaker: Dr. Cristina Solé Marce, Main researcher, Rheumatology (VHIR)

Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disease with a wide range of manifestations and organ involvement. Lupus nephritis (LN) occurs in 40-75% of SLE patients and is associated with an unpredictable course. Despite conventional therapy, LN is still one of the main causes of short- and long-term morbidity and mortality, with up to 30% of patients progressing to chronic renal failure. There is a need to find new, more effective, selective and targeted treatments. In this sense, the new chemical antigen receptor (CAR) technology that depletes B cells has proven to be a good possible alternative and the first clinical trials have already begun. In our group, we have studied a variant of this technology, the chimeric autoantigen receptor T-receptor therapy (CAAR-T) that selectively depletes anticoagulant B cells using the NZBWF1/J spontaneous lupus murine model. At the same time, we are also interested in the use of nanotechnology to encapsulate immunosuppressive drugs and selectively target them to the rontium. In this seminar, the results of these two research projects will be presented.

Host: eCORE AVANT (VHIR)


 

Related activities

IV Split Liver Transplantation Course: Theoretical and Practical Aspects

03/06/2024 - 09:00
More information

Actualización en el diagnóstico y tratamiento de las enfermedades digestivas

03/07/2024 - 09:00
More information

Preceptorship Hiperoxal·luria primària

Hospital Vall d’Hebron. Edifici General (entrada principal) Planta Baixa Sala 6 de Subdirecció. Pg Vall d'Hebron 119-129. Barcelona
03/14/2024 - 09:00
More information

V360 Simulación en Cirugía Vascular versión 3.0

03/27/2024 - 17:00
Especialistas de Angiología y Cirugía Vascular y residentes en formación con el siguiente perfil: • Médicos en formación en Angiología y Cirugía Vascular de 5º año • Especialista de Angiología y Cirugía Vascular de menos de 10 años de experiencia
More information

Subscribe to our newsletters and be a part of Vall d'Hebron Campus

Select the newsletter you want to receive:

By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to web@vallhebron.cat, clearly stating the subject as "Exercising of Data Protection Rights".
Operated by: Vall d’Hebron University Hospital Foundation – Research Institute.
Purpose: Manage the user’s contact information.
Legitimisation: Express acceptance of the privacy policy.
Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use.
Source: The interested party themselves.